Fluorescent in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes that bind to only those parts of the chromosome with a high degree of sequence complementarity.
Increasing demand for In Vitro Diagnostics (IVD) testing in the diagnosis of various chronic diseases is expected to drive the demand in coming years. Growing demand for IVD is attributed towards the high levels of reliability, rapidity, and sensitivity and is expected to propel FISH probe market growth.

The global Fluorescent In Situ Hybridization (FISH) Probe market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fluorescent In Situ Hybridization (FISH) Probe volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fluorescent In Situ Hybridization (FISH) Probe market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fluorescent In Situ Hybridization (FISH) Probe in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fluorescent In Situ Hybridization (FISH) Probe manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Oxford Gene Technology
Life Science Technologies
PerkinElmer
Abnova
Biosearch Technologies
Genemed
Roche
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
mRNA
miRNA

Segment by Application
Cancer research
Genetic diseases